-
Pakketadvies tebentafusp (Kimmtrak) - oogkanker
Advies om vergoeding te verlenen voor de aangegeven groep; uitgebreide bijlagen en WAR-verslagen beschikbaar. -
Pakketadvies bimekizumab (Bimzelx) - artritis psoriatica
Advies om vergoeding te verlenen; minister heeft besluit per 2 oktober 2024. -
Pakketadvies lebrikizumab (Ebglyss) - eczeem
Advies positief; minister besloot vergoeding per 18 december 2024 voor de genoemde patiënten. -
Pakketadvies niraparib-abirateron (Akeega) - uitgezaaide prostaatkanker
Zorginstituut adviseert niet te vergoeden voor de beoordeelde indicatie. -
Pakketadvies etranacogene dezaparvovec (Hemgenix) - hemofilie B
Advies gestuurd naar minister; beschrijft voorwaarden en patiëntselectie voor vergoeding. -
Pakketadvies efgartigimod alfa (Vyvgart) - myasthenia gravis
Het Zorginstituut adviseert opname in het basispakket na prijsonderhandelingen; vergoeding vanaf 14-11-2024. -
Pakketadvies lisocabtagene maraleucel (Breyanzi) - (herziene/december)
Herziene advies/version met nadere specificatie; ministeriële besluitvorming vermeld in update. -
Pakketadvies risankizumab (Skyrizi) - colitis ulcerosa
Advies positief; minister besloot vergoeding (inwerkingtreding vermeld in update). -
Pakketadvies olipudase alfa (Xenpozyme) - Niemann-Pick
Advies om na prijsonderhandelingen te vergoeden; rapport bevat achtergrond, effectiviteit en budgetimpact. -
Test Dataset
Minimal valid Health-RI dataset -
Athero- and Aneurysm-Express Biobank Studies
The Athero-Express Biobank Study (AE) and the Abdominal Aortic Aneurysm-Express Biobank Study (AAA) are two ongoing, prospective biobank studies initiated in 2002 and 2003,... -
'Utrecht cohort for Multiple BReast cancer intErvention studies and...
The prospective, multicenter ‘Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaluAtion’ (UMBRELLA) cohort, established in 2013, serves as an... -
MARS - Molecular Diagnosis and Risk Stratification of Sepsis
MARS is a multicenter prospective cohort of ICU patients aimed at developing new molecular technologies for early diagnosis and risk stratification of sepsis. MARS contains... -
European Prospective Investigation Into Cancer and Nutrition in the...
EPIC is the European Prospective Investigation Into Cancer and Nutrition. EPIC-NL is the Dutch contribution to EPIC and comprises about 40,000 individuals prospectively followed... -
Twin cohort for the study of (pre)clinical Inflammatory Bowel Disease in the...
Inflammatory Bowel Diseases (IBD), i.e. Crohn’s Disease (CD) and Ulcerative Colitis (UC), are thought to arise in genetically susceptible individuals in the context of... -
PROTOCOL ALL 11: Treatment study protocol of the Dutch Childhood Oncology...
- To improve the overall outcome as compared to the previous protocols of the DCOG, especially ALL-9 and ALL-10. This is aimed for by decreasing therapy for part of the...
-
Virus Interactions in the Respiratory Tract; a Cohort Study With Children (VIOOL)
The VIOOL study is a prospective observational cohort conducted across three winter seasons (2021–2024; October–April/May) in the Netherlands. Children under 4 years of age were... -
Long-term prosthesis survival of total hip and total knee arthroplasty in...
In this single center retrospective cohort study, regular care data of total knee arthroplasty and total hip arthroplasty was extracted from medical records of people with... -
BioDay Registry
The BioDay registry is a disease or condition registry for atopic dermatitis (AD)/prurigo nodularis (PN). All patients treated with advanced systemic therapy (biologics and JAK... -
Julius Huisartsen Netwerk
The Julius General Practitioners Network (JHN) is a database of primary care routine data. It is a network of approximately seventy general practices with two hundred general...
U kunt ook het register raadplegen met behulp van de API (see API documentatie).